Ausgabe 2/2011
Inhalt (7 Artikel)
Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges
Laura Catena, Emilio Bajetta, Massimo Milione, Monika Ducceschi, Monica Valente, Francesca Dominoni, Valentina Colonna
Clinical activity of mammalian target of rapamycin inhibitors in solid tumors
Yesid Alvarado, Monica M. Mita, Sushma Vemulapalli, Devalingam Mahalingam, Alain C. Mita
Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences
Hakan Cam, Peter J. Houghton
Targeting phosphatidylinositol 3 kinase (PI3K)-Akt beyond rapalogs
Shin Ogita, Patricia LoRusso
Predictive biomarkers for the activity of mammalian target of rapamycin (mTOR) inhibitors
Catherine Delbaldo, Sébastien Albert, Chantal Dreyer, Marie-Paule Sablin, Maria Serova, Eric Raymond, Sandrine Faivre
Common toxicities of mammalian target of rapamycin inhibitors
Scott A. Soefje, Anand Karnad, Andrew J. Brenner